Xeno Holdings

Xeno Holdings is a global investment group based in Hong Kong and South Korea that focuses on high-growth sectors, including biotechnology, healthcare, and digital assets. The firm operates as a strategic investor and incubator, providing capital and operational support to clinical-stage life science companies. Notable investments include Xeno Biosciences, which is developing novel therapeutics for obesity, and various ventures in the regenerative medicine space. By leveraging its network in the Asia-Pacific region, Xeno Holdings aims to bridge the gap between innovative Western biotechnology and the rapidly expanding Asian healthcare market.